CD5L contributes to the pathogenesis of methicillin-resistant Staphylococcus aureus-induced pneumonia

Xun Gao1, Xingxing Yan2, Qun Zhang3

  • 1Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China; Key Laboratory of Diagnostic Medicine designated by the Ministry of Education, Chongqing Medical University, Chongqing, China.

Insights

This study reveals that CD5L protein levels increase during Staphylococcus aureus pneumonia. Targeting CD5L with an antibody improved survival by reducing inflammation and bacterial load in mice.

Area of Science:

  • Immunology
  • Microbiology
  • Pulmonology

Background:

  • Staphylococcus aureus is a primary cause of community- and healthcare-acquired pneumonia.
  • CD5L is a key regulator of immune homeostasis.

Purpose of the Study:

  • To investigate the role of CD5L in Staphylococcus aureus pneumonia.
  • To evaluate the therapeutic potential of targeting CD5L in S. aureus pneumonia.

Main Methods:

  • Measurement of CD5L levels in patients and mice with S. aureus pneumonia.
  • Administration of anti-CD5L antibody or recombinant CD5L in a mouse model.
  • Assessment of bacterial clearance, survival rates, and pulmonary inflammatory markers.

Main Results:

  • Elevated circulating and lung CD5L levels were observed in S. aureus pneumonia.
  • Anti-CD5L antibody treatment enhanced survival, bacterial clearance, and reduced pulmonary inflammation.
  • Recombinant CD5L exacerbated S. aureus pneumonia lethality.

Conclusions:

  • CD5L plays a significant role in the immunopathology of S. aureus pneumonia.
  • Targeting CD5L represents a potential therapeutic strategy for S. aureus pneumonia.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
819
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.8K
Binet's Contribution to Measures of Intelligence01:23

Binet's Contribution to Measures of Intelligence

Alfred Binet, along with his student Théophile Simon, was tasked by the French Ministry of Education in 1904 to create a method for identifying students who struggled to learn through conventional classroom instruction. This initiative aimed to address overcrowding by placing such students in specialized schools. Binet and Simon developed an intelligence test comprising 30 tasks, ranging from simple commands, like touching one's nose or ear, to more complex tasks, such as drawing...
1.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
747
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
604